HK1152293A1 - Thiazole derivative and use thereof as vap-1 inhibitor vap-1 - Google Patents
Thiazole derivative and use thereof as vap-1 inhibitor vap-1Info
- Publication number
- HK1152293A1 HK1152293A1 HK11106277.8A HK11106277A HK1152293A1 HK 1152293 A1 HK1152293 A1 HK 1152293A1 HK 11106277 A HK11106277 A HK 11106277A HK 1152293 A1 HK1152293 A1 HK 1152293A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vap
- inhibitor
- thiazole derivative
- thiazole
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008021588 | 2008-01-31 | ||
PCT/JP2009/052015 WO2009096609A1 (en) | 2008-01-31 | 2009-01-30 | Thiazole derivative and use thereof as vap-1 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1152293A1 true HK1152293A1 (en) | 2012-02-24 |
Family
ID=40546096
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11106277.8A HK1152293A1 (en) | 2008-01-31 | 2011-06-20 | Thiazole derivative and use thereof as vap-1 inhibitor vap-1 |
HK13112767.1A HK1185348A1 (en) | 2008-01-31 | 2013-11-14 | Thiazole derivative and use thereof as vap-1 inhibitor vap-1 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13112767.1A HK1185348A1 (en) | 2008-01-31 | 2013-11-14 | Thiazole derivative and use thereof as vap-1 inhibitor vap-1 |
Country Status (18)
Country | Link |
---|---|
US (1) | US8507690B2 (xx) |
EP (4) | EP2252604B1 (xx) |
JP (1) | JP5415430B2 (xx) |
KR (1) | KR101622414B1 (xx) |
CN (1) | CN101932568B (xx) |
AR (1) | AR070336A1 (xx) |
AU (1) | AU2009209885B2 (xx) |
BR (1) | BRPI0906352A2 (xx) |
CA (1) | CA2712962C (xx) |
DK (1) | DK2639229T3 (xx) |
ES (2) | ES2527014T3 (xx) |
HK (2) | HK1152293A1 (xx) |
MX (1) | MX2010008460A (xx) |
NZ (1) | NZ587205A (xx) |
PT (1) | PT2639229E (xx) |
RU (1) | RU2496776C9 (xx) |
TW (1) | TWI437986B (xx) |
WO (1) | WO2009096609A1 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為vap-1抑制劑之用途 |
UA112154C2 (uk) * | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
US8802666B2 (en) * | 2009-12-21 | 2014-08-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Inhibitors of cyclophilins and uses thereof |
TWI594764B (zh) * | 2010-04-12 | 2017-08-11 | 生化治療公司 | 治療用途 |
ES2628850T3 (es) * | 2011-03-15 | 2017-08-04 | Astellas Pharma Inc. | Compuesto de guanidina |
WO2014199171A1 (en) | 2013-06-12 | 2014-12-18 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
WO2015189534A1 (en) | 2014-06-12 | 2015-12-17 | Proximagen Limited | Vap-1 inhibitors for treating muscular dystrophy |
JP2018080113A (ja) | 2015-05-27 | 2018-05-24 | 株式会社アールテック・ウエノ | 脳梗塞処置剤 |
JP2018076236A (ja) | 2015-06-05 | 2018-05-17 | 株式会社アールテック・ウエノ | がんを処置するための医薬組成物 |
FR3037954B1 (fr) * | 2015-06-24 | 2017-08-11 | Michelin & Cie | Procede de synthese de molecules azo-dicarbonylees porteuses de groupes associatifs |
AU2016366635A1 (en) | 2015-12-07 | 2018-06-21 | Benevolentai Cambridge Limited | VAP-1 inhibitors for treating pain |
WO2018097294A1 (ja) * | 2016-11-28 | 2018-05-31 | 帝人ファーマ株式会社 | 糖尿病性腎症の治療薬または予防薬 |
US11883461B2 (en) | 2019-05-09 | 2024-01-30 | The Feinstein Institutes For Medical Research | HMGB1 antagonist treatment of severe sepsis |
CA3139104A1 (en) * | 2019-05-09 | 2020-11-12 | The Feinstein Institutes For Medical Research | Thiosemicarbazates and uses thereof |
EP3965792A4 (en) | 2019-05-09 | 2023-01-18 | The Feinstein Institutes for Medical Research | HMGB1 ANTAGONIST |
SE544131C2 (en) * | 2020-03-16 | 2022-01-04 | Pvac Medical Tech Ltd | Use of substance and pharmaceutical composition thereof, and medical treatments or uses thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1181871B (it) | 1985-04-01 | 1987-09-30 | Consiglio Nazionale Ricerche | Inibitori selettivi delle benzilamminossidasi rispetto ad altre amminossidasi |
TW205041B (xx) * | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co | |
AU4055593A (en) | 1992-05-15 | 1993-12-13 | University Of Saskatchewan | Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis |
US6114365A (en) * | 1999-08-12 | 2000-09-05 | Pharmacia & Upjohn S.P.A. | Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
RU2003103286A (ru) | 2000-07-05 | 2004-08-20 | Байотай Терапис Корпорейшн (Fi) | Ингибиторы медьсодержащих аминооксидаз |
ES2168084B1 (es) | 2000-11-07 | 2003-11-16 | Univ Barcelona | Combinacion de aminas y compuestos de vanadio (iv) (v) para el tratatamiento y/o la prevencion de la diabetes mellitus. |
AU2002214505A1 (en) | 2000-11-09 | 2002-05-21 | Biovitrum Ab | New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives |
CN100491361C (zh) * | 2003-01-27 | 2009-05-27 | 安斯泰来制药有限公司 | 噻唑衍生物及其作为vap-1抑制剂的用途 |
CA2514573A1 (en) * | 2003-01-27 | 2004-08-12 | Astellas Pharma Inc. | Thiazole derivatives and their use as vap-1 inhibitors |
US20060229346A1 (en) * | 2003-03-31 | 2006-10-12 | Sucampo Ag | Method for treating vascular hyperpermeable disease |
CN1933833B (zh) * | 2004-03-18 | 2011-09-07 | 株式会社·R-技术上野 | 含有噻唑衍生物的含水组合物 |
CA2575411A1 (en) | 2004-07-27 | 2006-02-02 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 inhibitory activity |
CA2579889A1 (en) | 2004-09-09 | 2006-03-16 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 inhibitory activity |
TW200835687A (en) * | 2006-11-30 | 2008-09-01 | R Tech Ueno Ltd | Thiazole derivatives and their use as VAP-1 inhibitor |
EP2172221A4 (en) | 2007-06-25 | 2010-06-23 | R Tech Ueno Ltd | COMPOSITION FOR OPHTHALMIC DISEASE ASSOCIATED WITH HYPOXIA OR ISCHEMIA |
JPWO2009051223A1 (ja) | 2007-10-19 | 2011-03-03 | 株式会社アールテック・ウエノ | 白内障処置のための医薬組成物 |
-
2009
- 2009-01-23 TW TW098102784A patent/TWI437986B/zh not_active IP Right Cessation
- 2009-01-30 PT PT131721268T patent/PT2639229E/pt unknown
- 2009-01-30 MX MX2010008460A patent/MX2010008460A/es active IP Right Grant
- 2009-01-30 WO PCT/JP2009/052015 patent/WO2009096609A1/en active Application Filing
- 2009-01-30 EP EP09705640.2A patent/EP2252604B1/en not_active Not-in-force
- 2009-01-30 DK DK13172126.8T patent/DK2639229T3/da active
- 2009-01-30 AU AU2009209885A patent/AU2009209885B2/en not_active Ceased
- 2009-01-30 KR KR1020107017937A patent/KR101622414B1/ko not_active IP Right Cessation
- 2009-01-30 RU RU2010136301/04A patent/RU2496776C9/ru not_active IP Right Cessation
- 2009-01-30 JP JP2010529187A patent/JP5415430B2/ja not_active Expired - Fee Related
- 2009-01-30 NZ NZ587205A patent/NZ587205A/en not_active IP Right Cessation
- 2009-01-30 EP EP13185390.5A patent/EP2676955B1/en not_active Not-in-force
- 2009-01-30 ES ES13172126.8T patent/ES2527014T3/es active Active
- 2009-01-30 BR BRPI0906352-8A patent/BRPI0906352A2/pt active Search and Examination
- 2009-01-30 CN CN200980103755.1A patent/CN101932568B/zh not_active Expired - Fee Related
- 2009-01-30 EP EP13172126.8A patent/EP2639229B9/en not_active Not-in-force
- 2009-01-30 ES ES09705640.2T patent/ES2452834T3/es active Active
- 2009-01-30 EP EP13172130.0A patent/EP2650287B9/en not_active Not-in-force
- 2009-01-30 CA CA2712962A patent/CA2712962C/en not_active Expired - Fee Related
- 2009-01-30 AR ARP090100311A patent/AR070336A1/es unknown
- 2009-01-30 US US12/864,773 patent/US8507690B2/en not_active Expired - Fee Related
-
2011
- 2011-06-20 HK HK11106277.8A patent/HK1152293A1/xx not_active IP Right Cessation
-
2013
- 2013-11-14 HK HK13112767.1A patent/HK1185348A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1185348A1 (en) | Thiazole derivative and use thereof as vap-1 inhibitor vap-1 | |
HK1210612A1 (en) | Benzene or thiophene derivative and use thereof as vap-1 inhibitor vap-1 | |
HK1254895A1 (zh) | 苄基苯衍生物及使用方法 | |
HK1172896A1 (zh) | 化合物和使用方法 | |
HK1161094A1 (en) | Compounds and methods of use | |
IL210055A0 (en) | Thiophene or thiazole derivatives and their use as pi3k inhibitors | |
IL192634A0 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
ZA201003596B (en) | Haloallylamine inhibitors of ssao/vap-1 and uses thereof | |
EP2264017A4 (en) | Heterocyclic derivative and its use | |
EP2383263A4 (en) | NEW THIAZOLIDINEDIONE DERIVATIVE AND ITS APPLICATIONS | |
IL196956A0 (en) | Aza-benzofuranyl compounds and methods of use | |
IL211042A0 (en) | Imidazopyridin-2-one derivatives and uses thereof | |
ZA201103635B (en) | Azaquinolinone derivatives and uses thereof | |
GB0812031D0 (en) | Thiazole derivatives | |
IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
HK1149933A1 (en) | Diazacarbazoles and methods of use | |
HK1137756A1 (en) | Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors hif--4- | |
IL209548A0 (en) | Diazacarbazoles and methods of use | |
EP2231625A4 (en) | KINASE INHIBITORS BASED ON THIAZOLE AND OXAZOLE | |
IL208771A0 (en) | Iminopyridine derivatives and use thereof | |
IL196594A0 (en) | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors | |
ZA200907727B (en) | Cinnamaldehyde formulations and methods of use | |
IL208824A0 (en) | Iminopyridine derivative and use thereof | |
ZA200900896B (en) | Aza-benzofuranyl compounds and methods of use | |
HK1167406A1 (en) | Pyrazolone-derivatives and their use as pd4 inhibitors pd4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190128 |